Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ASML vs GSK✓SelectedUSD · GSKASML vs GSK performance historyLatest closeAs of-0.13%11/13
Stock and ETF performance explorer

ASML vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,557.1%
GSK return
+105.0%
Excess return
+1,452.2%
Maximum drawdown
-56.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%+0.5%-0.7%-0.3%
7D+4.9%+1.1%+3.8%+4.5%
30D-9.3%+6.3%-15.6%-11.5%
3M-19.0%+1.8%-20.8%-20.1%
6M-5.2%+1.7%-6.9%-7.2%
YTD+40.6%+6.5%+34.1%+34.6%
1Y+47.5%+9.5%+38.0%+39.5%
3Y+133.9%+65.3%+68.6%+76.1%
5Y+83.8%+43.7%+40.1%+45.8%
All+1,557.1%+105.0%+1,452.2%+1,026.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling